Dev

According to a recent study from a team of researchers at Tel Aviv University, a mutation in a specific neuroprotective protein called ADNP has different expressions between males and females. This research adds new insights to what is currently known…

With several therapeutic approaches in development for Huntington’s disease, there is a need for easily accessible biomarkers to monitor disease progression and therapy response. Researchers at Leiden University Medical Center in The Netherlands have discovered a panel of five genes…

Belgian scientists have completed a study, reprogramming skin cells from three dementia patients into induced pluripotent stem cells (iPSCs) – immature cells that mimic stem cells taken from early-stage embryos. Their findings, which revealed a signalling pathway linked to frontotemporal…

In acknowledgement of the high societal relevance of neuroscientific research, a joint transnational call on “Ethical, Legal, and Social Aspects (ELSA) of Neuroscience” was launched by the ERANET-NEURON network on January 9, 2015. The aim of the call is to…

Parkinson’s disease has an insidious onset and is diagnosed when typical motor features occur. Several motor and non-motor features can occur before diagnosis, early in the disease process. This study aimed to assess the association between first presentation of several…

Some cases of Alzheimer’s disease progress quickly, mimicking prion-based Creutzfeldt-Jakob disease (CJD). Many people with this form of Alzheimer’s are misdiagnosed, because clinicians have no reliable way to distinguish between the two disorders. In the January 5 JAMA Neurology, researchers…

The personal genetics company 23andMe, Inc. has announced an agreement with Genentech, a member of the Roche Group, to generate whole genome sequencing data for approximately 3,000 people in 23andMe’s Parkinson’s disease community. The goal of the collaboration is to…